Compare DexCom, Inc. (DXCM) vs Direxion Daily Semiconductor Bull 3X Shares (SOXL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs Direxion Daily Semiconductor Bull 3X Shares — how do they compare? DexCom, Inc. trades at $77.55 (market cap $28.06B), while Direxion Daily Semiconductor Bull 3X Shares trades at $151.55. The key difference: DexCom, Inc. is trading nearer its 52-week high, Direxion Daily Semiconductor Bull 3X Shares nearer its low. Which is the better fit depends on your goals.
| DXCM | SOXL | |
|---|---|---|
Market Cap | $28.06B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $89.53 | $300.77 |
52-Week Low | $54.84 | $23.99 |
Enterprise Value | $27.03B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DexCom (DXCM) trades at $74.12, down 2.92% on the day, with a bullish technical signal from moving averages. The company demonstrates strong fundamentals with consistent revenue growth, expanding profit margins, and a track record of beating earnings estimates. Recent regulatory approvals for its G7 15-day CGM in Canada and pediatric clearance for its Stelo OTC system in the U.S. highlight ongoing product expansion.
The investment thesis centers on DexCom's leadership in the growing CGM market, supported by strong financial execution and analyst optimism. Key risks include competition from Abbott, the commercial unproven nature of expansion into non-insulin Type 2 diabetes patients, and potential disruption from GLP-1 drug adoption. The consensus price target of $84.33 suggests ~14% upside from current levels.
SOXL, the Direxion Daily Semiconductor Bull 3X Shares ETF, is trading at $145.35, down 17.72% in the past 24 hours amid a broader semiconductor selloff. Technical indicators show a bearish trend with support at $125 and resistance at $178, while RSI levels near 35 suggest potential oversold conditions. Recent news highlights volatility driven by SK Hynix's U.S. listing and increased competition in memory chips, impacting leveraged ETF performance.
The outlook for SOXL remains highly volatile due to its 3x leverage on semiconductor stocks, amplifying both gains and losses. Investment opportunity exists if semiconductor sentiment rebounds, but risks include decay from choppy markets and sector-specific pressures. Caution is warranted given the bearish technical signals and recent institutional selling.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About Direxion Daily Semiconductor Bull 3X Shares
SOXL is a leveraged ETF that seeks daily investment results corresponding to 300% of the daily performance of the ICE Semiconductor Index. It is designed as a tactical tool for experienced traders to take a bullish (long) position on the semiconductor sector. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment.
Read more on SOXL →
